Welcome to FDAweb
Pay Per View
Search our 72,318 - story database FREE
Free Items
 Warning Letters
 FDA Notices
 FDA Calendar

 FDA Whistleblowers


Blood Products Panel to Meet

Federal Register Notice: FDA will hold a meeting of the Blood Products Advisory Committee 11/17 from 8 a.m. to 5:30 p.m. and 11/18, from 8:30 a.m. to 1 p.m. at FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. Contact Bryan Emery or Joanne Lipkind, (240) 402-8054, bryan.emery@fda.hhs.gov and (240) 402-8106, joanne.lipkind@fda.hhs.gov. The committee will meet in open session to discuss strategies to manage iron deficiency associated with blood donation. It will also discuss proposed procedures for assuring donor safety for collections of blood from female donors with hemoglobin values of 12.0-12.4g/dL or a hematocrit value between 36 and 38. In the afternoon, the committee will meet in open session to discuss adverse reactions related to blood donation in teenage (16 to 18 years) donors, and the effectiveness of several mitigation measures.
On 11/18, the committee will meet to hear an informational session on Zika virus and blood safety in the U.S. Following the informational session, the committee will hear presentations on (1) The Transfusion Transmissible Infections Monitoring System; (2) a summary of the FDA workshop on new methods to predict the immunogenicity of therapeutic coagulation proteins; and (3) a summary of the FDA workshop on preclinical evaluation of red blood cells for transfusion. To view this notice, click here.

Any copying or electronic transfer without written permission is strictly prohibited and will result
in termination of service and prosecution under the federal Copyright Act.
To gain permission to copy this article log on to http://www.copyright.com.

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com